MeSH Review:
Intracranial Thrombosis
- Screening for neuroborreliosis in patients with stroke. Hammers-Berggren, S., Gröndahl, A., Karlsson, M., von Arbin, M., Carlsson, A., Stiernstedt, G. Stroke (1993)
- Vascular reconstruction using interposed small vessels. Houkin, K., Ishikawa, T., Kuroda, S., Abe, H. Neurosurgery (1998)
- Nicardipine in the treatment of outpatients with cerebrovascular disorders. Lozano, R., Balaguer, A. Clinical therapeutics. (1991)
- Cerebrovascular acetazolamide reactivity and platelet function in asymptomatic cerebral thrombosis. Oishi, M., Mochizuki, Y. J. Neurol. Sci. (1999)
- Plasma semicarbazide-sensitive amine oxidase in stroke. Garpenstrand, H., Ekblom, J., von Arbin, M., Oreland, L., Murray, V. Eur. Neurol. (1999)
- Upregulated expression of 14-3-3 proteins in astrocytes from human cerebrovascular ischemic lesions. Kawamoto, Y., Akiguchi, I., Tomimoto, H., Shirakashi, Y., Honjo, Y., Budka, H. Stroke (2006)
- Cerebral thrombosis, cerebral haemorrhage, and ABO blood-groups. Ionescu, D.A., Marcu, I., Bicescu, E. Lancet (1976)
- Letter: Tranexamic acid and intracranial thrombosis. Rydin, E., Lundberg, P.O. Lancet (1976)
- Protease nexin-2/amyloid beta-protein precursor limits cerebral thrombosis. Xu, F., Davis, J., Miao, J., Previti, M.L., Romanov, G., Ziegler, K., Van Nostrand, W.E. Proc. Natl. Acad. Sci. U.S.A. (2005)
- Tissue plasminogen activator (tPA) deficiency exacerbates cerebrovascular fibrin deposition and brain injury in a murine stroke model: studies in tPA-deficient mice and wild-type mice on a matched genetic background. Tabrizi, P., Wang, L., Seeds, N., McComb, J.G., Yamada, S., Griffin, J.H., Carmeliet, P., Weiss, M.H., Zlokovic, B.V. Arterioscler. Thromb. Vasc. Biol. (1999)
- Induction of cerebral thrombosis with phenytoin in rats. Tani, S., Shimizu, T., Kasuya, H., Iwasaki, H., Takashima, K. Stroke (1995)
- Platelet volume, aggregation, and adenosine triphosphate release in cerebral thrombosis. Tohgi, H., Suzuki, H., Tamura, K., Kimura, B. Stroke (1991)
- Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Ward, A., Clissold, S.P. Drugs (1987)
- Cerebral thrombosis associated with Amicar therapy. Hoffman, E.P., Koo, A.H. Radiology. (1979)
- Protective effects of imidapril on He-Ne laser-induced thrombosis in cerebral blood vessels of stroke-prone spontaneously hypertensive rats. Sasaki, Y., Noguchi, T., Seki, J., Giddings, J.C., Yamamoto, J. Thromb. Haemost. (2000)
- Thrombosis following desmopressin for uremic bleeding. Byrnes, J.J., Larcada, A., Moake, J.L. Am. J. Hematol. (1988)
- Inhibition of collagen-induced platelet aggregation by argatroban in patients with acute cerebral infarction. Imiya, M., Matsuo, T. Thromb. Res. (1997)
- Protein C deficiency associated with massive cerebral thrombosis following open heart surgery. Ridley, P.D., Ledingham, S.J., Lennox, S.C., Burman, J.F., Chung, H.I., Sheffield, E.A., Talbot, S., Bevan, D. The Journal of cardiovascular surgery. (1990)
- Plasma levels of thrombomodulin and lipoprotein (a) in patients with cerebral thrombosis. Seki, Y., Takahashi, H., Shibata, A., Aizawa, Y. Blood Coagul. Fibrinolysis (1997)
- Erythrocyte rheology in acute cerebral thrombosis. Effects of ABO blood groups. Ionescu, D.A., Ghitescu, M., Marcu, I., Xenakis, A. Blut (1979)
- Dissolution of emboli in rats with experimental cerebral thromboembolism by recombinant human tissue plasminogen activator (TD-2061). Hara, T., Iwamoto, M., Ogawa, H., Yamamoto, A., Tomikawa, M. Thromb. Res. (1990)
- Circulating hepatocyte growth factor as a diagnostic marker of thrombus formation in patients with cerebral infarction. Matsumori, A., Takano, H., Obata, J.E., Takeda, S., Tsuyuguchi, N., Ono, K., Okada, M., Miyamoto, T., Ohnishi, T., Daikuhara, Y., Sasayama, S. Circ. J. (2002)
- Severe arterial cerebral thrombosis in a patient with protein S deficiency (moderately reduced total and markedly reduced free protein S): a family study. Girolami, A., Simioni, P., Lazzaro, A.R., Cordiano, I. Thromb. Haemost. (1989)
- Variations of alpha 2-plasmin inhibitor, antithrombin III, plasminogen in the serum of patients of cerebral thrombosis infused with urokinase. Takada, A., Takada, Y., Uemura, K., Nakajima, S., Ryu, H., Ninchoji, T. Thromb. Res. (1979)
- A simple and reproducible cerebral thrombosis model in rats induced by a photochemical reaction and the effect of a plasminogen-plasminogen activator chimera in this model. Matsuno, H., Uematsu, T., Umemura, K., Takiguchi, Y., Asai, Y., Muranaka, Y., Nakashima, M. Journal of pharmacological and toxicological methods. (1993)
- Effect of argatroban, a selective thrombin inhibitor, on animal models of cerebral thrombosis. Tamao, Y., Kikumoto, R. Semin. Thromb. Hemost. (1997)
- Development of argatroban as an anticoagulant and antithrombin agent in Japan. Ikoma, H. Pathophysiol. Haemost. Thromb. (2002)